Alnylam Pharmaceuticals, Inc. - Common Stock (NQ:ALNY)Price and VolumeDetailed Quote
Top NewsMore News
Top US Stock Gainers and Losers for Oct. 29, 2026 ↗
October 29, 2026
Via Chartmill
Performance
52-Week Range
66.8% below 52-week high
159.16
156.0052W Low
479.7952W High
1 Week
31.7% below 1-week high
156.001W Low
232.881W High
Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) traded between $156.00 and $479.79 over the past 52 weeks and last traded at $159.16, 66.8% below its 52-week high. Over the past week it ranged between $156.00 and $232.88.
Past 12 Months
-29.8%
-27.6%
-27.8%
-46.6%
-60.2%
-63.3%
1W
-$67.62
1M
-$60.72
3M
-$61.17
6M
-$138.76
YTD
-$241.01
1Y
-$274.90
ALNY was -63.3% over the past year, -46.6% over six months, -60.2% year to date, -29.8% in the last week.
12 Months vs Market
ALNY
DIA
SPY
QQQ
IWM
Over the past 12 months ALNY returned -63.3% versus DIA (Dow) +9.4%, SPY (S&P 500) +10.6%, QQQ (Nasdaq 100) +8.7% and IWM (Russell 2000) +14.5%.
Volume & Liquidity
1.13× 3-mo avg
Today 2,113,704
3-mo avg 1.9M
1W
1M
3M
6M
YTD
1Y
ALNY most recently traded 2,113,704 shares against a 3-month average daily volume of 1.9M. More NewsRead More
Alnylam (ALNY) Q3 2026 Earnings Call Transcript ↗
October 29, 2026
Via The Motley Fool
Topics
Earnings
Alnylam Pharmaceuticals (NASDAQ:ALNY): Affordable Growth in Biotech ↗
September 03, 2026
Via Chartmill
Alnylam Pharmaceuticals Q3 Earnings Call Highlights ↗
October 29, 2026
Via MarketBeat
Topics
Earnings
Premarket Gainers and Losers on Oct. 29, 2026 ↗
October 29, 2026
Via Chartmill
Via MarketBeat
Alnylam vs. Ionis: Here's the Better Bad-News Buy ↗
October 10, 2026
Via The Motley Fool
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right. ↗
September 28, 2026
Via The Motley Fool
Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook ↗
September 20, 2026
Via MarketBeat
Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial ↗
September 19, 2026
Via MarketBeat
Topics
Death
Alnylam to Webcast Presentations at Upcoming September Investor Conferences
September 02, 2026
Via Business Wire
Frequently Asked QuestionsIs Alnylam Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Alnylam Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Alnylam Pharmaceuticals, Inc. - Common Stock trade on?
Alnylam Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock is ALNY on the Nasdaq Stock Market
What is the current price of Alnylam Pharmaceuticals, Inc. - Common Stock?
The current price of Alnylam Pharmaceuticals, Inc. - Common Stock is 159.16
When was Alnylam Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Alnylam Pharmaceuticals, Inc. - Common Stock was at 11/03/26 02:21 PM ET
What is the market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock is 18.92B
How many shares of Alnylam Pharmaceuticals, Inc. - Common Stock are outstanding?
Alnylam Pharmaceuticals, Inc. - Common Stock has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>